1.
|
11 p, 703.9 KB |
Risk of Trypanosoma cruzi infection among travellers visiting friends and relatives to continental Latin America
/
Sánchez-Montalvá, Adrián (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Salinas, Catalina (Universitat Autònoma de Barcelona) ;
Sullerio, Elena (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Salvador, Fernando (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Bosch-Nicolau, Pau (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Crespillo-Andújar, Clara (Hospital Universitario Ramón y Cajal (Madrid)) ;
Trigo, Elena (Hospital Universitario La Paz (Madrid)) ;
Roure, Silvia (Universitat Autònoma de Barcelona) ;
Valerio, Lluís (Universitat Autònoma de Barcelona) ;
Espinosa-Pereiro, Juan (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Molina Romero, Israel (Hospital Universitari Vall d'Hebron. Institut de Recerca)
Chagas disease (CD) is regarded as a possible risk for travellers to endemic areas of continental Latin America (LA). The aim of the study is to determine the risk of Trypanosoma cruzi (TC) infection among travellers to CD endemic areas and to identify risk factors for acquiring TC infection. [...]
2021 - 10.1371/journal.pntd.0009528
PLoS neglected tropical diseases, Vol. 15 (july 2021)
|
|
2.
|
10 p, 1.3 MB |
Benznidazole Treatment : Time- and Dose-Dependence Varies with the Trypanosoma cruzi Strain
/
Fonseca, Kátia da Silva (Federal University of Ouro Preto) ;
Perin, Luísa (University of Ouro Preto) ;
de Paiva, Nívia Carolina Nogueira (Federal University of Ouro Preto) ;
da Silva, Beatriz Cristiane (Federal University of Ouro Preto) ;
Duarte, Thays Helena Chaves (Federal University of Ouro Pretotment of Biological Sciences, Nucleus of Biological Sciences Research) ;
Marques, Flávia de Souza (Federal University of Ouro Preto) ;
Costa, Guilherme de Paula (Federal University of Ouro Preto) ;
Molina, Israel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Correa-Oliveira, Rodrigo (Oswaldo Cruz Foundation) ;
Vieira, Paula Melo de Abreu (Federal University of Ouro Preto) ;
Carneiro, Cláudia Martins (Federal University of Ouro Preto) ;
Universitat Autònoma de Barcelona
As the development of new drugs for Chagas disease is not a priority due to its neglected disease status, an option for increasing treatment adherence is to explore alternative treatment regimens, which may decrease the incidence of side effects. [...]
2021 - 10.3390/pathogens10060729
Pathogens, Vol. 10 (june 2021)
|
|
3.
|
|
4.
|
9 p, 1.2 MB |
Intra-Discrete Typing Unit TcV Genetic Variability of Trypanosoma cruzi in Chronic Chagas' Disease Bolivian Immigrant Patients in Barcelona, Spain
/
de Oliveira, Maykon Tavares (University of São Paulo) ;
Sulleiro, Elena (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
da Silva, Maria Cláudia (University of São Paulo) ;
Silgado, Aroa (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
de Lana, Marta (Federal University of Ouro Preto) ;
da Silva, João Santana (Fiocruz-Bi-Institutional Translational Medicine Plataform) ;
Molina Romero, Israel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Marin-Neto, J. Antônio (University of São Paulo) ;
Universitat Autònoma de Barcelona
Background: Trypanosoma cruzi has a high rate of biological and genetic variability, and its population structure is divided into seven distinct genetic groups (TcI-TcVI and Tcbat). Due to immigration, Chagas disease (ChD), caused by T. [...]
2021 - 10.3389/fcvm.2021.665624
Frontiers in Cardiovascular Medicine, Vol. 8 (may 2021)
|
|
5.
|
8 p, 1.7 MB |
Blastocystis sp. Carriage and Irritable Bowel Syndrome : Is the Association Already Established?
/
Salvador, Fernando (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Lobo, Beatriz (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Goterris, Lidia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Alonso Cotoner, Carmen (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Santos, Javier (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Sulleiro, Elena (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Bailo, Begoña (National Centre of Microbiology, Instituto de Salud Carlos III, 28220 Madrid, Spain; (B.B.); (D.C.); (I.F.)) ;
Carmena, David (National Centre of Microbiology, Instituto de Salud Carlos III, 28220 Madrid, Spain; (B.B.); (D.C.); (I.F.)) ;
Sánchez-Montalvá, Adrián (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Bosch-Nicolau, Pau (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Espinosa-Pereiro, Juan (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Fuentes, Isabel (National Centre of Microbiology, Instituto de Salud Carlos III, 28220 Madrid, Spain; (B.B.); (D.C.); (I.F.)) ;
Molina, Israel (Hospital Universitari Vall d'Hebron. Institut de Recerca)
The intestinal protist Blastocystis sp. is one of the most common intestinal parasites observed in humans, and has a worldwide distribution, being more prevalent in developing countries. Although this parasite has been described decades ago, the pathogenic potential it is still not understood completely. [...]
2021 - 10.3390/biology10040340
Biology, Vol. 10 (april 2021)
|
|
6.
|
6 p, 148.0 KB |
Clinical and Microbiological Profile of a Retrospective Cohort of Enteric Fever in 2 Spanish Tertiary Hospitals
/
Sánchez-Montalvá, Adrián (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Martínez-Pérez, Ángela (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Pérez-Molina, José Antonio (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
González-López, Juanjo (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Lopez-Vélez, Rogelio (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Salvador, Fernando (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Sánchez, Irene (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Planes, Anna M. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Molina Romero, Israel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Universitat Autònoma de Barcelona
Enteric fever in high-income countries is diagnosed mainly in patients returning from endemic countries. We assess the clinical, microbiological, and prognosis aspects of enteric fever in 2 Spanish tertiary hospitals. [...]
2015 - 10.1097/MD.0000000000000791
Medicine, Vol. 94 (may 2015)
|
|
7.
|
6 p, 213.7 KB |
Epidemiology and Diagnosis of Tuberculous Lymphadenitis in a Tuberculosis Low-Burden Country
/
Salvador, Fernando (Hospital Universitari Vall d'Hebron) ;
Los-Arcos, Ibai (Hospital Universitari Vall d'Hebron) ;
Sánchez-Montalvá, Adrián (Hospital Universitari Vall d'Hebron) ;
Tórtola Fernández, María Teresa (Hospital Universitari Vall d'Hebron) ;
Curran, Adrian (Hospital Universitari Vall d'Hebron) ;
Villar, A (Hospital Universitari Vall d'Hebron) ;
Saborit, Nuria (Hospital Universitari Vall d'Hebron) ;
Castellvi, Josep (Hospital Universitari Vall d'Hebron) ;
Molina Romero, Israel (Hospital Universitari Vall d'Hebron) ;
Universitat Autònoma de Barcelona
The aim of this article is to describe epidemiological and clinical data of patients with tuberculous lymphadenitis (TL) and evaluate the yield of the diagnostic techniques employed. Retrospective observational study was performed at the Vall d'Hebron University Hospital, Barcelona, Spain. [...]
2015 - 10.1097/MD.0000000000000509
Medicine, Vol. 94 (january 2015)
|
|
8.
|
7 p, 469.0 KB |
Epidemiological and clinical profile of adult patients with Blastocystis sp. infection in Barcelona, Spain
/
Salvador, Fernando (Hospital Universitari Vall d'Hebron) ;
Sulleiro, Elena (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Sánchez-Montalvá, Adrián (Hospital Universitari Vall d'Hebron) ;
Alonso Cotoner, Carmen (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Santos, Javier (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Fuentes, Isabel (Instituto de Salud Carlos III, National Centre of Microbiology, Madrid, Spain) ;
Molina Romero, Israel (Hospital Universitari Vall d'Hebron)
Blastocystis spp. are among the most frequently observed intestinal parasites in humans. Despite the discovery of Blastocystis approximately 100 years ago, limited information is available regarding its pathogenesis, genetic diversity, and available treatment options. [...]
2016 - 10.1186/s13071-016-1827-4
Parasites & vectors, Vol. 9 (october 2016)
|
|
9.
|
13 p, 207.1 KB |
Chagas Cardiomyopathy : Usefulness of EKG and Echocardiogram in a Non-Endemic Country
/
Sánchez-Montalvá, Adrián (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Salvador, Fernando (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Rodríguez Palomares, José Fernando (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Sulleiro, Elena (Hospital Universitari Vall d'Hebron) ;
Sao-Avilés, Augusto (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Roure, Sílvia (Universitat Autònoma de Barcelona) ;
Valerio, Lluís (Universitat Autònoma de Barcelona) ;
Evangelista Masip, Arturo (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Molina, Israel (Hospital Universitari Vall d'Hebron. Institut de Recerca)
Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original. Chagas disease (CD) is a major cause of cardiomyopathy in Latin America, and migration movements have now spread the disease worldwide. However, data regarding Chagas cardiomyopathy (CC) and the usefulness of echocardiography in non endemic countries are still scarce. [...]
2016 - 10.1371/journal.pone.0157597
PloS one, Vol. 11 (june 2016)
|
|
10.
|
15 p, 1.6 MB |
First external quality assurance program for bloodstream Real-Time PCR monitoring of treatment response in clinical trials of Chagas disease
/
Ramírez, Juan C. (Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres") ;
Parrado, Rudy (Universidad Mayor de San Simón) ;
Sulleiro, Elena (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
de la Barra, Anabelle (Universidad Mayor de San Simón, Cochabamba, Bolivia) ;
Rodríguez, Marcelo (Instituto Nacional de Enfermedades Infecciosas "Dr. Carlos G. Malbrán") ;
Villarroel, Sandro (Universidad Mayor de San Simón) ;
Irazu, Lucía (Instituto Nacional de Enfermedades Infecciosas "Dr. Carlos G. Malbrán") ;
Alonso-Vega, Cristina (Drugs for Neglected Diseases initiative) ;
Alves, Fabiana (Drugs for Neglected Diseases initiative (Suïssa)) ;
Curto, María A. (Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres") ;
García, Lineth (Universidad Mayor de San Simón) ;
Ortiz, Lourdes (Universidad Autónoma Juan Misael Saracho) ;
Torrico, Faustino (Fundación CEADES) ;
Gascon, Joaquim (Barcelona Institute for Global Health (ISGlobal)) ;
Flevaud, Laurence (Médecins Sans Frontières Operational Center Barcelona-Athens) ;
Molina Romero, Israel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Ribeiro, Isabela (Drugs for Neglected Diseases initiative (Suïssa)) ;
Schijman, Alejandro G. (Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres") ;
Universitat Autònoma de Barcelona
Real-Time PCR (qPCR) testing is recommended as both a diagnostic and outcome measurement of etiological treatment in clinical practice and clinical trials of Chagas disease (CD), but no external quality assurance (EQA) program provides performance assessment of the assays in use. [...]
2017 - 10.1371/journal.pone.0188550
PloS one, Vol. 12 (november 2017)
|
|